Gitlab Inc vs Teladoc Health Inc — how do they compare? Gitlab Inc trades at $55.09 (market cap $8.92B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Gitlab Inc is far larger — about 8.8× Teladoc Health Inc's market cap, and Gitlab Inc is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gitlab Inc for 62 Days and Teladoc Health Inc for 39 Days on average.
| GTLB | TDOC | |
|---|---|---|
Market Cap | $8.92B | $1.01B |
Volume | 4,716,893 | 4,668,477 |
Sector | Technology | Health |
52-Week High | $55.09 | $9.72 |
52-Week Low | $19.42 | $4.47 |
Typical Hold Time | 62 Days | 39 Days |
Enterprise Value | $7.66B | $1.27B |
Signals from Pluang's Aura AI — not financial advice
GitLab (GTLB) trades at $53.56, up 3.02% with strong technical momentum as it approaches resistance at $54. The stock shows bullish moving average signals despite an overbought RSI. Fundamentally, revenue growth remains robust at 21.3% in Q2 2026 with consistent earnings beats, though profitability metrics like negative net income margin and ROE highlight ongoing challenges. Recent news highlights AI-driven product traction and raised guidance, fueling investor optimism.
Outlook: GitLab's AI integration and sales momentum support upside potential, but high valuation multiples and persistent cash burn pose risks. Analyst consensus is mixed with a $49.71 price target below current levels, suggesting cautious optimism amid execution and competitive pressures.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →